Charles River Laboratorie...

NYSE: CRL · Real-Time Price · USD
156.64
0.84 (0.54%)
At close: Aug 15, 2025, 3:59 PM
156.68
0.03%
After-hours: Aug 15, 2025, 05:29 PM EDT

Charles River Laboratories International Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 28, 2025 Mar 29, 2025 Dec 28, 2024 Sep 28, 2024 Jun 29, 2024 Mar 30, 2024 Dec 30, 2023 Sep 30, 2023 Jul 1, 2023 Apr 1, 2023 Dec 31, 2022 Sep 24, 2022 Jun 25, 2022 Mar 26, 2022 Dec 25, 2021 Sep 25, 2021 Jun 26, 2021 Mar 27, 2021
Net Income
-64.88M -23.31M 25.29M 427.99M 445.72M 450.9M 479.55M 479.7M 488.15M 498.03M 490.13M 440.85M 449.53M 430.13M 398.84M 403.2M 400.65M 378.4M
Depreciation & Amortization
430.17M 396.75M 361.74M 340.15M 330.82M 322.41M 314.12M 311.15M 306.89M 305.64M 303.87M 293.57M 287.65M 279.33M 265.54M 259.18M 250.07M 239.17M
Stock-Based Compensation
66.75M 66.29M 69.89M 72.18M 75.64M 75.33M 72.05M 74.6M 73.8M 72.46M 73.62M 70.73M 70.76M 72.9M 71.47M 67.66M 62.5M 58.57M
Other Working Capital
9.34M 667K -54.47M 11.89M -12.86M -5.88M 13.78M 207.3M 210.26M 296.62M 253.36M 56.18M 30.26M 5.58M 49.83M 37.31M 80.53M 101.73M
Other Non-Cash Items
421.7M 403.1M 375.41M -45.98M -36.22M -45.4M -28.54M -46.05M -54.39M -56.98M -59.53M 10.95M -3.46M -21.42M 6.01M -31.45M -47.78M -62M
Deferred Income Tax
-95.39M -85.48M -67.43M -48.64M -47.42M -40.31M -50.9M -37.81M -37.76M -39.91M -35.88M -36.57M -47.58M -22.44M -24.01M -10.76M 8.61M -6.29M
Change in Working Capital
29.09M 19.05M -30.33M 50.46M -18.73M -58.53M -102.38M -83.88M -151.66M -152.85M -152.55M -165.39M -100.81M -45.3M 42.94M -17.91M -1.55M 40.35M
Operating Cash Flow
787.45M 776.39M 734.58M 796.16M 749.82M 704.4M 683.9M 697.71M 625.04M 626.39M 619.64M 614.14M 656.08M 693.2M 760.8M 669.92M 672.5M 648.21M
Capital Expenditures
-208.96M -213.15M -232.97M -235.67M -262.9M -290.8M -318.53M -329.23M -335.68M -351.14M -324.73M -334.48M -317.63M -281.21M -228.77M -217.85M -188.5M -168.87M
Cash Acquisitions
n/a 11.96M -5.48M -150.1M -84.15M -153.55M -203.71M 104.18M 38.23M -170.28M -120.12M -161.7M -453.29M -1.08B -1.17B -1.29B -1.04B -130.57M
Purchase of Investments
-25.43M -44.31M -52.88M -63.16M -67.06M -55.51M -54.22M -65.23M -72.12M -157.55M -158.27M -142.96M -131.13M -42.3M -45.55M -38.77M -37.89M -36.12M
Sales Maturities Of Investments
31.43M 35.79M 41.69M 42.18M 16.08M 12.22M 6.67M 5.4M 7.29M 6.3M 4.55M 3.68M 1.53M 6.74M 6.53M 11.55M 10.92M 8.9M
Other Investing Acitivies
22.71M 4.94M 4.55M -608K -67.55M 7.31M 6.63M 4.48M 69.25M -5.86M -9.35M -7.54M -5.35M -4.97M 264K 981K 931K 813K
Investing Cash Flow
-180.25M -204.77M -245.09M -407.35M -465.59M -480.33M -563.15M -280.4M -293.03M -678.53M -607.92M -643M -905.86M -1.4B -1.44B -1.54B -1.25B -325.86M
Debt Repayment
100.9M -153.64M -412.19M -217.66M -286.21M -102.09M -75.32M -452.36M -339.71M 41.23M 19.79M 14.98M 236.06M 443.9M 669.98M 868.87M 422.04M -214.28M
Common Stock Repurchased
-100.91M -462.96M -119.17M -119.19M -18.44M -14.49M -24.16M -24.18M -24.16M -23.67M -38.65M -38.76M -38.88M -38.67M -40.71M -40.51M -40.48M -36.33M
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
539M -58M -19.56M -20.57M -8.09M 18.23M -3.77M 6.7M 5.3M -33.22M -23.54M 11.36M 20.89M 59.37M 43.32M 3.98M 3.25M 13.37M
Financial Cash Flow
-615.66M -674.6M -550.93M -351.48M -306.81M -92.42M -85.52M -458.05M -346.77M -3.87M -42.4M -12.41M 218.08M 464.6M 672.6M 832.34M 384.81M -237.24M
Net Cash Flow
3.74M -107.1M -79.21M 45.73M -28.07M 129.64M 43.27M -30.56M 1.57M -34.48M -5.08M -30.3M -20.26M -227.63M 13.2M -20.92M -176.55M 96.57M
Free Cash Flow
578.5M 563.24M 501.61M 560.48M 486.92M 413.61M 365.37M 368.48M 289.37M 275.25M 294.91M 279.66M 338.46M 411.99M 532.03M 452.07M 484M 479.35M